<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1986-07-21" modified="2016-04-13" version="214">
<accession>P02647</accession>
<accession>A8K866</accession>
<accession>Q6LDN9</accession>
<accession>Q6Q785</accession>
<accession>Q9UCS8</accession>
<accession>Q9UCT8</accession>
<name>APOA1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Apolipoprotein A-I</fullName>
<shortName>Apo-AI</shortName>
<shortName>ApoA-I</shortName>
</recommendedName>
<alternativeName>
<fullName>Apolipoprotein A1</fullName>
</alternativeName>
<component>
<recommendedName>
<fullName>Proapolipoprotein A-I</fullName>
<shortName>ProapoA-I</shortName>
</recommendedName>
</component>
<component>
<recommendedName>
<fullName>Truncated apolipoprotein A-I</fullName>
</recommendedName>
<alternativeName>
<fullName>Apolipoprotein A-I(1-242)</fullName>
</alternativeName>
</component>
</protein>
<gene>
<name type="primary">APOA1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1983" name="Nucleic Acids Res." volume="11" first="2827" last="2837">
<title>Gene structure of human apolipoprotein A1.</title>
<authorList>
<person name="Shoulders C.C."/>
<person name="Kornblihtt A.R."/>
<person name="Munro B.S."/>
<person name="Baralle F.E."/>
</authorList>
<dbReference type="PubMed" id="6406984"/>
<dbReference type="DOI" id="10.1093/nar/11.9.2827"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1983" name="Nucleic Acids Res." volume="11" first="3703" last="3715">
<title>Nucleotide sequence of cloned cDNA of human apolipoprotein A-I.</title>
<authorList>
<person name="Cheung P."/>
<person name="Chan L."/>
</authorList>
<dbReference type="PubMed" id="6304641"/>
<dbReference type="DOI" id="10.1093/nar/11.11.3703"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1983" name="Proc. Natl. Acad. Sci. U.S.A." volume="80" first="6147" last="6151">
<title>Isolation and characterization of the human apolipoprotein A-I gene.</title>
<authorList>
<person name="Karathanasis S.K."/>
<person name="Zannis V.I."/>
<person name="Breslow J.L."/>
</authorList>
<dbReference type="PubMed" id="6413973"/>
<dbReference type="DOI" id="10.1073/pnas.80.20.6147"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1984" name="DNA" volume="3" first="309" last="317">
<title>Isolation and DNA sequence of full-length cDNA and of the entire gene for human apolipoprotein AI -- discovery of a new genetic polymorphism in the apo AI gene.</title>
<authorList>
<person name="Seilhamer J.J."/>
<person name="Protter A.A."/>
<person name="Frossard P."/>
<person name="Levy-Wilson B."/>
</authorList>
<dbReference type="PubMed" id="6207999"/>
<dbReference type="DOI" id="10.1089/dna.1.1984.3.309"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1984" name="Nucleic Acids Res." volume="12" first="3917" last="3932">
<title>Human apolipoproteins AI, AII, CII and CIII. cDNA sequences and mRNA abundance.</title>
<authorList>
<person name="Sharpe C.R."/>
<person name="Sidoli A."/>
<person name="Shelley C.S."/>
<person name="Lucero M.A."/>
<person name="Shoulders C.C."/>
<person name="Baralle F.E."/>
</authorList>
<dbReference type="PubMed" id="6328445"/>
<dbReference type="DOI" id="10.1093/nar/12.9.3917"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1984" name="Proc. Natl. Acad. Sci. U.S.A." volume="81" first="66" last="70">
<title>Nucleotide sequence and the encoded amino acids of human apolipoprotein A-I mRNA.</title>
<authorList>
<person name="Law S.W."/>
<person name="Brewer H.B. Jr."/>
</authorList>
<dbReference type="PubMed" id="6198645"/>
<dbReference type="DOI" id="10.1073/pnas.81.1.66"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1985" name="J. Biol. Chem." volume="260" first="12810" last="12814">
<title>Tangier disease. The complete mRNA sequence encoding for preproapo-A-I.</title>
<authorList>
<person name="Law S.W."/>
<person name="Brewer H.B. Jr."/>
</authorList>
<dbReference type="PubMed" id="2995392"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1988" name="Eur. J. Biochem." volume="173" first="465" last="471">
<title>Sequence and expression of Tangier apoA-I gene.</title>
<authorList>
<person name="Makrides S.C."/>
<person name="Ruiz-Opazo N."/>
<person name="Hayden M.R."/>
<person name="Nussbaum A.L."/>
<person name="Breslow J.L."/>
<person name="Zannis V.I."/>
</authorList>
<dbReference type="PubMed" id="3129297"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1988.tb14022.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (VARIANT TANGIER)</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1989" name="DNA" volume="8" first="429" last="436">
<title>Production of human recombinant proapolipoprotein A-I in Escherichia coli: purification and biochemical characterization.</title>
<authorList>
<person name="Moguilevsky N."/>
<person name="Roobol C."/>
<person name="Loriau R."/>
<person name="Guillaume J.P."/>
<person name="Jacobs P."/>
<person name="Cravador A."/>
<person name="Herzog A."/>
<person name="Brouwers L."/>
<person name="Scarso A."/>
<person name="Gilles P."/>
<person name="Holmquist L."/>
<person name="Carlson L.A."/>
<person name="Bollen A."/>
</authorList>
<dbReference type="PubMed" id="2673706"/>
<dbReference type="DOI" id="10.1089/dna.1.1989.8.429"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Hum. Genet." volume="115" first="36" last="56">
<title>The effects of scale: variation in the APOA1/C3/A4/A5 gene cluster.</title>
<authorList>
<person name="Fullerton S.M."/>
<person name="Buchanan A.V."/>
<person name="Sonpar V.A."/>
<person name="Taylor S.L."/>
<person name="Smith J.D."/>
<person name="Carlson C.S."/>
<person name="Salomaa V."/>
<person name="Stengaard J.H."/>
<person name="Boerwinkle E."/>
<person name="Clark A.G."/>
<person name="Nickerson D.A."/>
<person name="Weiss K.M."/>
</authorList>
<dbReference type="PubMed" id="15108119"/>
<dbReference type="DOI" id="10.1007/s00439-004-1106-x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT THR-61</scope>
</reference>
<reference key="11">
<citation type="patent" date="1988-11-30" number="EP0293357">
<title>Expression of human proapolipoprotein A-1.</title>
<authorList>
<person name="Bollen A."/>
<person name="Gobert J."/>
<person name="Wuelfert E."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="13">
<citation type="submission" date="2007-02" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NHLBI resequencing and genotyping service (RS&amp;G)"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="14">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
<tissue>Skeletal muscle</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="1983" name="Biochem. Biophys. Res. Commun." volume="113" first="626" last="632">
<title>Human plasma proapoA-I: isolation and amino-terminal sequence.</title>
<authorList>
<person name="Brewer H.B. Jr."/>
<person name="Fairwell T."/>
<person name="Kay L."/>
<person name="Meng M."/>
<person name="Ronan R."/>
<person name="Law S."/>
<person name="Light J.A."/>
</authorList>
<dbReference type="PubMed" id="6409108"/>
<dbReference type="DOI" id="10.1016/0006-291X(83)91772-2"/>
</citation>
<scope>PROTEIN SEQUENCE OF 19-27</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1975" name="J. Biol. Chem." volume="250" first="2725" last="2738">
<title>The primary structure of human plasma high density apolipoprotein glutamine I (ApoA-I). II. The amino acid sequence and alignment of cyanogen bromide fragments IV, III, and I.</title>
<authorList>
<person name="Baker H.N."/>
<person name="Gotto A.M. Jr."/>
<person name="Jackson R.L."/>
</authorList>
<dbReference type="PubMed" id="164450"/>
</citation>
<scope>PROTEIN SEQUENCE OF 25-267</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1978" name="Biochem. Biophys. Res. Commun." volume="80" first="623" last="630">
<title>The amino acid sequence of human APOA-I, an apolipoprotein isolated from high density lipoproteins.</title>
<authorList>
<person name="Brewer H.B. Jr."/>
<person name="Fairwell T."/>
<person name="Larue A."/>
<person name="Ronan R."/>
<person name="Houser A."/>
<person name="Bronzert T.J."/>
</authorList>
<dbReference type="PubMed" id="204308"/>
<dbReference type="DOI" id="10.1016/0006-291X(78)91614-5"/>
</citation>
<scope>PROTEIN SEQUENCE OF 25-267</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1988" name="J. Clin. Invest." volume="82" first="803" last="807">
<title>Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I.</title>
<authorList>
<person name="Yui Y."/>
<person name="Aoyama T."/>
<person name="Morishita H."/>
<person name="Takahashi M."/>
<person name="Takatsu Y."/>
<person name="Kawai C."/>
</authorList>
<dbReference type="PubMed" id="3047170"/>
<dbReference type="DOI" id="10.1172/JCI113682"/>
</citation>
<scope>PROTEIN SEQUENCE OF 25-56</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1991" name="Biochemistry" volume="30" first="8986" last="8990">
<title>Identification of apolipoprotein A1 and immunoglobulin as components of a serum complex that mediates activation of human sperm motility.</title>
<authorList>
<person name="Aakerloef E."/>
<person name="Joernvall H."/>
<person name="Slotte H."/>
<person name="Pousette A."/>
</authorList>
<dbReference type="PubMed" id="1909888"/>
<dbReference type="DOI" id="10.1021/bi00101a011"/>
</citation>
<scope>PROTEIN SEQUENCE OF 25-50</scope>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN THE SPAP COMPLEX</scope>
<source>
<tissue>Serum</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="1989" name="J. Biol. Chem." volume="264" first="16853" last="16857">
<title>Apolipoprotein A-I binds to a family of bovine seminal plasma proteins.</title>
<authorList>
<person name="Manjunath P."/>
<person name="Marcel Y.L."/>
<person name="Uma J."/>
<person name="Seidah N.G."/>
<person name="Chretien M."/>
<person name="Chapdelaine A."/>
</authorList>
<dbReference type="PubMed" id="2506184"/>
</citation>
<scope>PROTEIN SEQUENCE OF 25-48</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1987" name="Science" volume="238" first="1417" last="1419">
<title>Similarity of cruzin, an inhibitor of Trypanosoma cruzi neuraminidase, to high-density lipoprotein.</title>
<authorList>
<person name="Prioli R.P."/>
<person name="Ordovas J.M."/>
<person name="Rosenberg I."/>
<person name="Schaeffer E.J."/>
<person name="Pereira M.E.A."/>
</authorList>
<dbReference type="PubMed" id="3120314"/>
<dbReference type="DOI" id="10.1126/science.3120314"/>
</citation>
<scope>PROTEIN SEQUENCE OF 25-43</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1994" name="Electrophoresis" volume="15" first="1459" last="1465">
<title>The human myocardial two-dimensional gel protein database: update 1994.</title>
<authorList>
<person name="Corbett J.M."/>
<person name="Wheeler C.H."/>
<person name="Baker C.S."/>
<person name="Yacoub M.H."/>
<person name="Dunn M.J."/>
</authorList>
<dbReference type="PubMed" id="7895732"/>
<dbReference type="DOI" id="10.1002/elps.11501501209"/>
</citation>
<scope>PROTEIN SEQUENCE OF 25-42</scope>
<source>
<tissue>Heart</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2003" name="Nat. Biotechnol." volume="21" first="566" last="569">
<title>Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides.</title>
<authorList>
<person name="Gevaert K."/>
<person name="Goethals M."/>
<person name="Martens L."/>
<person name="Van Damme J."/>
<person name="Staes A."/>
<person name="Thomas G.R."/>
<person name="Vandekerckhove J."/>
</authorList>
<dbReference type="PubMed" id="12665801"/>
<dbReference type="DOI" id="10.1038/nbt810"/>
</citation>
<scope>PROTEIN SEQUENCE OF 25-34</scope>
<source>
<tissue>Platelet</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="1991" name="Biochim. Biophys. Acta" volume="1086" first="255" last="260">
<title>The apolipoprotein A-I binding protein of placenta and the SP-40,40 protein of human blood are different proteins which both bind to apolipoprotein A-I.</title>
<authorList>
<person name="Ehnholm C."/>
<person name="Bozas S.E."/>
<person name="Tenkanen H."/>
<person name="Kirszbaum L."/>
<person name="Metso J."/>
<person name="Murphy B."/>
<person name="Walker I.D."/>
</authorList>
<dbReference type="PubMed" id="1742316"/>
<dbReference type="DOI" id="10.1016/0005-2760(91)90167-G"/>
</citation>
<scope>PROTEIN SEQUENCE OF 25-33</scope>
<scope>INTERACTION WITH APOA1BP AND CLU</scope>
</reference>
<reference key="26">
<citation type="submission" date="2008-12" db="UniProtKB">
<authorList>
<person name="Lubec G."/>
<person name="Vishwanath V."/>
<person name="Chen W.-Q."/>
<person name="Sun Y."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 35-64; 70-101; 121-140; 165-173; 185-195 AND 240-263</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Brain</tissue>
<tissue>Cajal-Retzius cell</tissue>
<tissue>Fetal brain cortex</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="1982" name="Proc. Natl. Acad. Sci. U.S.A." volume="79" first="6861" last="6865">
<title>Isolation and characterization of cDNA clones for human apolipoprotein A-I.</title>
<authorList>
<person name="Breslow J.L."/>
<person name="Ross D."/>
<person name="McPherson J."/>
<person name="Williams H.W."/>
<person name="Kurnit D."/>
<person name="Nussbaum A.L."/>
<person name="Karathanasis S.K."/>
<person name="Zannis V.I."/>
</authorList>
<dbReference type="PubMed" id="6294659"/>
<dbReference type="DOI" id="10.1073/pnas.79.22.6861"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 118-267</scope>
</reference>
<reference key="28">
<citation type="journal article" date="1986" name="J. Biol. Chem." volume="261" first="3911" last="3914">
<title>Human apolipoprotein A-I. Post-translational modification by fatty acid acylation.</title>
<authorList>
<person name="Hoeg J.M."/>
<person name="Meng M.S."/>
<person name="Ronan R."/>
<person name="Fairwell T."/>
<person name="Brewer H.B. Jr."/>
</authorList>
<dbReference type="PubMed" id="3005308"/>
</citation>
<scope>PALMITOYLATION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="1983" name="Proc. Natl. Acad. Sci. U.S.A." volume="80" first="2574" last="2578">
<title>Intracellular and extracellular processing of human apolipoprotein A-I: secreted apolipoprotein A-I isoprotein 2 is a propeptide.</title>
<authorList>
<person name="Zannis V.I."/>
<person name="Karathanasis S.K."/>
<person name="Keutmann H.T."/>
<person name="Goldberger G."/>
<person name="Breslow J.L."/>
</authorList>
<dbReference type="PubMed" id="6405383"/>
<dbReference type="DOI" id="10.1073/pnas.80.9.2574"/>
</citation>
<scope>PROTEOLYTIC PROCESSING</scope>
</reference>
<reference key="30">
<citation type="journal article" date="1993" name="Clin. Chim. Acta" volume="217" first="193" last="198">
<title>The preferential site of non-enzymatic glycation of human apolipoprotein A-I in vivo.</title>
<authorList>
<person name="Calvo C."/>
<person name="Ulloa N."/>
<person name="Campos M."/>
<person name="Verdugo C."/>
<person name="Ayrault-Jarrier M."/>
</authorList>
<dbReference type="PubMed" id="8261628"/>
<dbReference type="DOI" id="10.1016/0009-8981(93)90165-Z"/>
</citation>
<scope>GLYCATION AT LYS-263</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2002" name="Genomics" volume="79" first="693" last="702">
<title>Cloning and characterization of a novel apolipoprotein A-I-binding protein, AI-BP, secreted by cells of the kidney proximal tubules in response to HDL or ApoA-I.</title>
<authorList>
<person name="Ritter M."/>
<person name="Buechler C."/>
<person name="Boettcher A."/>
<person name="Barlage S."/>
<person name="Schmitz-Madry A."/>
<person name="Orso E."/>
<person name="Bared S.M."/>
<person name="Schmiedeknecht G."/>
<person name="Baehr C.H."/>
<person name="Fricker G."/>
<person name="Schmitz G."/>
</authorList>
<dbReference type="PubMed" id="11991719"/>
<dbReference type="DOI" id="10.1006/geno.2002.6761"/>
</citation>
<scope>INTERACTION WITH APOA1BP</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2003" name="J. Lipid Res." volume="44" first="349" last="355">
<title>Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoprotein.</title>
<authorList>
<person name="Pankhurst G."/>
<person name="Wang X.L."/>
<person name="Wilcken D.E."/>
<person name="Baernthaler G."/>
<person name="Panzenboeck U."/>
<person name="Raftery M."/>
<person name="Stocker R."/>
</authorList>
<dbReference type="PubMed" id="12576517"/>
<dbReference type="DOI" id="10.1194/jlr.M200256-JLR200"/>
</citation>
<scope>MASS SPECTROMETRY</scope>
<scope>OXIDATION AT MET-110 AND MET-136</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2003" name="J. Lipid Res." volume="44" first="630" last="639">
<title>Novel mass spectrometric immunoassays for the rapid structural characterization of plasma apolipoproteins.</title>
<authorList>
<person name="Niederkofler E.E."/>
<person name="Tubbs K.A."/>
<person name="Kiernan U.A."/>
<person name="Nedelkov D."/>
<person name="Nelson R.W."/>
</authorList>
<dbReference type="PubMed" id="12562854"/>
<dbReference type="DOI" id="10.1194/jlr.D200034-JLR200"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2005" name="Biochem. Biophys. Res. Commun." volume="332" first="982" last="992">
<title>NDRG1 interacts with APO A-I and A-II and is a functional candidate for the HDL-C QTL on 8q24.</title>
<authorList>
<person name="Hunter M."/>
<person name="Angelicheva D."/>
<person name="Tournev I."/>
<person name="Ingley E."/>
<person name="Chan D.C."/>
<person name="Watts G.F."/>
<person name="Kremensky I."/>
<person name="Kalaydjieva L."/>
</authorList>
<dbReference type="PubMed" id="15922294"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2005.05.050"/>
</citation>
<scope>INTERACTION WITH NDRG1</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="37">
<citation type="journal article" date="2014" name="PLoS ONE" volume="9" first="E96150" last="E96150">
<title>Secondary structure changes in ApoA-I Milano (R173C) are not accompanied by a decrease in protein stability or solubility.</title>
<authorList>
<person name="Petrlova J."/>
<person name="Dalla-Riva J."/>
<person name="Morgelin M."/>
<person name="Lindahl M."/>
<person name="Krupinska E."/>
<person name="Stenkula K.G."/>
<person name="Voss J.C."/>
<person name="Lagerstedt J.O."/>
</authorList>
<dbReference type="PubMed" id="24755625"/>
<dbReference type="DOI" id="10.1371/journal.pone.0096150"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT MILANO CYS-197</scope>
</reference>
<reference key="38">
<citation type="journal article" date="1996" name="Biochim. Biophys. Acta" volume="1301" first="174" last="184">
<title>Conformation of human serum apolipoprotein A-I(166-185) in the presence of sodium dodecyl sulfate or dodecylphosphocholine by 1H-NMR and CD. Evidence for specific peptide-SDS interactions.</title>
<authorList>
<person name="Wang G."/>
<person name="Treleaven W.D."/>
<person name="Cushley R.J."/>
</authorList>
<dbReference type="PubMed" id="8664326"/>
<dbReference type="DOI" id="10.1016/0005-2760(96)00037-9"/>
</citation>
<scope>STRUCTURE BY NMR OF 190-209</scope>
</reference>
<reference key="39">
<citation type="journal article" date="1997" name="Proc. Natl. Acad. Sci. U.S.A." volume="94" first="12291" last="12296">
<title>Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation.</title>
<authorList>
<person name="Borhani D.W."/>
<person name="Rogers D.P."/>
<person name="Engler J.A."/>
<person name="Brouillette C.G."/>
</authorList>
<dbReference type="PubMed" id="9356442"/>
<dbReference type="DOI" id="10.1073/pnas.94.23.12291"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (4.0 ANGSTROMS) OF 67-267</scope>
</reference>
<reference key="40">
<citation type="journal article" date="1993" name="Biochem. Biophys. Res. Commun." volume="196" first="950" last="955">
<title>Autosomal dominant hypoalphalipoproteinemia due to a completely defective apolipoprotein A-I gene.</title>
<authorList>
<person name="Nakata K."/>
<person name="Kobayashi K."/>
<person name="Yanagi H."/>
<person name="Shimakura Y."/>
<person name="Tsuchiya S."/>
<person name="Arinami T."/>
<person name="Hamaguchi H."/>
</authorList>
<dbReference type="PubMed" id="8240372"/>
<dbReference type="DOI" id="10.1006/bbrc.1993.2341"/>
</citation>
<scope>DISEASE</scope>
</reference>
<reference key="41">
<citation type="journal article" date="1994" name="J. Clin. Invest." volume="93" first="223" last="229">
<title>Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia.</title>
<authorList>
<person name="Ng D.S."/>
<person name="Leiter L.A."/>
<person name="Vezina C."/>
<person name="Connelly P.W."/>
<person name="Hegele R.A."/>
</authorList>
<dbReference type="PubMed" id="8282791"/>
<dbReference type="DOI" id="10.1172/JCI116949"/>
</citation>
<scope>DISEASE</scope>
</reference>
<reference key="42">
<citation type="journal article" date="1983" name="J. Biol. Chem." volume="258" first="2508" last="2513">
<title>Apolipoprotein A-IMilano. Detection of normal A-I in affected subjects and evidence for a cysteine for arginine substitution in the variant A-I.</title>
<authorList>
<person name="Weisgraber K.H."/>
<person name="Rall S.C. Jr."/>
<person name="Bersot T.P."/>
<person name="Mahley R.W."/>
<person name="Franceschini G."/>
<person name="Sirtori C.R."/>
</authorList>
<dbReference type="PubMed" id="6401735"/>
</citation>
<scope>VARIANT MILANO CYS-197</scope>
</reference>
<reference key="43">
<citation type="journal article" date="1983" name="Proc. Natl. Acad. Sci. U.S.A." volume="80" first="6081" last="6085">
<title>Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-I) with high density lipoproteins.</title>
<authorList>
<person name="Schmitz G."/>
<person name="Assmann G."/>
<person name="Rall S.C. Jr."/>
<person name="Mahley R.W."/>
</authorList>
<dbReference type="PubMed" id="6412234"/>
<dbReference type="DOI" id="10.1073/pnas.80.19.6081"/>
</citation>
<scope>VARIANT TANGIER</scope>
</reference>
<reference key="44">
<citation type="journal article" date="1984" name="Eur. J. Biochem." volume="144" first="325" last="331">
<title>Apolipoprotein A-IGiessen (Pro143-->Arg). A mutant that is defective in activating lecithin:cholesterol acyltransferase.</title>
<authorList>
<person name="Utermann G."/>
<person name="Haas J."/>
<person name="Steinmetz A."/>
<person name="Paetzold R."/>
<person name="Rall S.C. Jr."/>
<person name="Weisgraber K.H."/>
<person name="Mahley R.W."/>
</authorList>
<dbReference type="PubMed" id="6489332"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1984.tb08467.x"/>
</citation>
<scope>VARIANT GIESSEN ARG-167</scope>
</reference>
<reference key="45">
<citation type="journal article" date="1984" name="J. Biol. Chem." volume="259" first="10063" last="10070">
<title>Abnormal lecithin:cholesterol acyltransferase activation by a human apolipoprotein A-I variant in which a single lysine residue is deleted.</title>
<authorList>
<person name="Rall S.C. Jr."/>
<person name="Weisgraber K.H."/>
<person name="Mahley R.W."/>
<person name="Ogawa Y."/>
<person name="Fielding C.J."/>
<person name="Utermann G."/>
<person name="Haas J."/>
<person name="Steinmetz A."/>
<person name="Menzel H.J."/>
<person name="Assmann G."/>
</authorList>
<dbReference type="PubMed" id="6432779"/>
</citation>
<scope>VARIANT NORWAY LYS-160</scope>
</reference>
<reference key="46">
<citation type="journal article" date="1988" name="Biochem. Biophys. Res. Commun." volume="156" first="762" last="768">
<title>Variant apolipoprotein AI as a major constituent of a human hereditary amyloid.</title>
<authorList>
<person name="Nichols W.C."/>
<person name="Dwulet F.E."/>
<person name="Liepnieks J."/>
<person name="Benson M.D."/>
</authorList>
<dbReference type="PubMed" id="3142462"/>
<dbReference type="DOI" id="10.1016/S0006-291X(88)80909-4"/>
</citation>
<scope>PROTEIN SEQUENCE OF 25-107</scope>
<scope>VARIANT AMYL8 ARG-50</scope>
</reference>
<reference key="47">
<citation type="journal article" date="1990" name="Genomics" volume="8" first="318" last="323">
<title>A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy.</title>
<authorList>
<person name="Nichols W.C."/>
<person name="Gregg R.E."/>
<person name="Brewer H.B. Jr."/>
<person name="Benson M.D."/>
</authorList>
<dbReference type="PubMed" id="2123470"/>
<dbReference type="DOI" id="10.1016/0888-7543(90)90288-6"/>
</citation>
<scope>VARIANT AMYL8 ARG-50</scope>
</reference>
<reference key="48">
<citation type="journal article" date="1990" name="Biochim. Biophys. Acta" volume="1043" first="169" last="176">
<title>Isolation and characterization of human apolipoprotein A-I Fukuoka (110 Glu-->Lys). A novel apolipoprotein variant.</title>
<authorList>
<person name="Takada Y."/>
<person name="Sasaki J."/>
<person name="Ogata S."/>
<person name="Nakanishi T."/>
<person name="Ikehara Y."/>
<person name="Arakawa K."/>
</authorList>
<dbReference type="PubMed" id="2107878"/>
<dbReference type="DOI" id="10.1016/0005-2760(90)90292-6"/>
</citation>
<scope>PROTEIN SEQUENCE OF 25-267</scope>
<scope>VARIANT FUKUOKA LYS-134</scope>
</reference>
<reference key="49">
<citation type="journal article" date="1992" name="Proc. Natl. Acad. Sci. U.S.A." volume="89" first="7389" last="7393">
<title>Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis.</title>
<authorList>
<person name="Soutar A.K."/>
<person name="Hawkins P.N."/>
<person name="Vigushin D.M."/>
<person name="Tennent G.A."/>
<person name="Booth S.E."/>
<person name="Hutton T."/>
<person name="Nguyen O."/>
<person name="Totty N.F."/>
<person name="Feest T.G."/>
<person name="Hsuan J.J."/>
<person name="Pepys M.B."/>
</authorList>
<dbReference type="PubMed" id="1502149"/>
<dbReference type="DOI" id="10.1073/pnas.89.16.7389"/>
</citation>
<scope>PROTEIN SEQUENCE OF 25-112</scope>
<scope>VARIANT AMYL8 ARG-84</scope>
</reference>
<reference key="50">
<citation type="journal article" date="1990" name="Hum. Genet." volume="84" first="439" last="445">
<title>Apolipoprotein A1 Baltimore (Arg-10-->Leu), a new ApoA1 variant.</title>
<authorList>
<person name="Ladias J.A.A."/>
<person name="Kwiterovich P.O. Jr."/>
<person name="Smith H.H."/>
<person name="Karathanasis S.K."/>
<person name="Antonarakis S.E."/>
</authorList>
<dbReference type="PubMed" id="2108924"/>
<dbReference type="DOI" id="10.1007/BF00195816"/>
</citation>
<scope>VARIANT BALTIMORE LEU-34</scope>
</reference>
<reference key="51">
<citation type="journal article" date="1989" name="J. Clin. Invest." volume="84" first="1722" last="1730">
<title>Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I.</title>
<authorList>
<person name="von Eckardstein A."/>
<person name="Funke H."/>
<person name="Henke A."/>
<person name="Altland K."/>
<person name="Benninghoven A."/>
<person name="Assmann G."/>
<person name="Welp S."/>
<person name="Roetrige A."/>
<person name="Kock R."/>
</authorList>
<dbReference type="PubMed" id="2512329"/>
<dbReference type="DOI" id="10.1172/JCI114355"/>
</citation>
<scope>VARIANTS ARG-27; ARG-28 AND ARG-189</scope>
</reference>
<reference key="52">
<citation type="journal article" date="1990" name="J. Biol. Chem." volume="265" first="8610" last="8617">
<title>Structural analysis of human apolipoprotein A-I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure.</title>
<authorList>
<person name="von Eckardstein A."/>
<person name="Funke H."/>
<person name="Walter M."/>
<person name="Altland K."/>
<person name="Benninghoven A."/>
<person name="Assmann G."/>
</authorList>
<dbReference type="PubMed" id="2111322"/>
</citation>
<scope>VARIANTS GLU-113; MET-131; GLY-163; VAL-171 AND LYS-222</scope>
</reference>
<reference key="53">
<citation type="journal article" date="1994" name="Biochim. Biophys. Acta" volume="1214" first="272" last="278">
<title>Characterization of two new human apolipoprotein A-I variants: apolipoprotein A-I Tsushima (Trp-108-->Arg) and A-I Hita (Ala-95-->Asp).</title>
<authorList>
<person name="Araki K."/>
<person name="Sasaki J."/>
<person name="Matsunaga A."/>
<person name="Takada Y."/>
<person name="Moriyama K."/>
<person name="Hidaka K."/>
<person name="Arakawa K."/>
</authorList>
<dbReference type="PubMed" id="7918609"/>
</citation>
<scope>VARIANTS HITA AND TSUSHIMA</scope>
</reference>
<reference key="54">
<citation type="journal article" date="1994" name="Q. J. Med." volume="87" first="149" last="154">
<title>Familial nephropathic systemic amyloidosis caused by apolipoprotein AI variant Arg26.</title>
<authorList>
<person name="Vigushin D.M."/>
<person name="Gough J."/>
<person name="Allan D."/>
<person name="Alguacil A."/>
<person name="Penner B."/>
<person name="Pettigrew N.M."/>
<person name="Quinonez G."/>
<person name="Bernstein K."/>
<person name="Booth S.E."/>
<person name="Booth D.R."/>
<person name="Soutar A.K."/>
<person name="Hawkins P.N."/>
<person name="Pepys M.B."/>
</authorList>
<dbReference type="PubMed" id="8208902"/>
</citation>
<scope>VARIANT AMYL8 ARG-50</scope>
</reference>
<reference key="55">
<citation type="journal article" date="1998" name="Arterioscler. Thromb. Vasc. Biol." volume="18" first="389" last="396">
<title>A novel homozygous missense mutation in the apo A-I gene with apo A-I deficiency.</title>
<authorList>
<person name="Huang W."/>
<person name="Sasaki J."/>
<person name="Matsunaga A."/>
<person name="Nanimatsu H."/>
<person name="Moriyama K."/>
<person name="Han H."/>
<person name="Kugi M."/>
<person name="Koga T."/>
<person name="Yamaguchi K."/>
<person name="Arakawa K."/>
</authorList>
<dbReference type="PubMed" id="9514407"/>
<dbReference type="DOI" id="10.1161/01.ATV.18.3.389"/>
</citation>
<scope>VARIANT AOITA GLU-180</scope>
</reference>
<reference key="56">
<citation type="journal article" date="1998" name="Hum. Mutat." volume="11" first="416" last="416">
<title>Apo A-I Zaragoza(L144R): a novel mutation in the apolipoprotein A-I gene associated with familial hypoalphalipoproteinemia.</title>
<authorList>
<person name="Recalde D."/>
<person name="Cenarro A."/>
<person name="Civeira F."/>
<person name="Pocovi M."/>
</authorList>
</citation>
<scope>VARIANT ZARAGOZA ARG-168</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2003" name="Hum. Mol. Genet." volume="12" first="2733" last="2743">
<title>Association of extreme blood lipid profile phenotypic variation with 11 reverse cholesterol transport genes and 10 non-genetic cardiovascular disease risk factors.</title>
<authorList>
<person name="Morabia A."/>
<person name="Cayanis E."/>
<person name="Costanza M.C."/>
<person name="Ross B.M."/>
<person name="Flaherty M.S."/>
<person name="Alvin G.B."/>
<person name="Das K."/>
<person name="Gilliam T.C."/>
</authorList>
<dbReference type="PubMed" id="12966036"/>
<dbReference type="DOI" id="10.1093/hmg/ddg314"/>
</citation>
<scope>VARIANT ILE-92</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2011" name="J. Mol. Cell Biol." volume="3" first="309" last="315">
<title>Quantitative detection of single amino acid polymorphisms by targeted proteomics.</title>
<authorList>
<person name="Su Z.D."/>
<person name="Sun L."/>
<person name="Yu D.X."/>
<person name="Li R.X."/>
<person name="Li H.X."/>
<person name="Yu Z.J."/>
<person name="Sheng Q.H."/>
<person name="Lin X."/>
<person name="Zeng R."/>
<person name="Wu J.R."/>
</authorList>
<dbReference type="PubMed" id="22028381"/>
<dbReference type="DOI" id="10.1093/jmcb/mjr024"/>
</citation>
<scope>VARIANT ILE-92</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2015" name="J. Clin. Lipidol." volume="9" first="390" last="395">
<title>Case report: A novel apolipoprotein A-I missense mutation apoA-I (Arg149Ser)Boston associated with decreased lecithin-cholesterol acyltransferase activation and cellular cholesterol efflux.</title>
<authorList>
<person name="Anthanont P."/>
<person name="Asztalos B.F."/>
<person name="Polisecki E."/>
<person name="Zachariah B."/>
<person name="Schaefer E.J."/>
</authorList>
<dbReference type="PubMed" id="26073399"/>
<dbReference type="DOI" id="10.1016/j.jacl.2015.02.005"/>
</citation>
<scope>VARIANT BOSTON SER-173</scope>
</reference>
<comment type="function">
<text evidence="11">Participates in the reverse transport of cholesterol from tissues to the liver for excretion by promoting cholesterol efflux from tissues and by acting as a cofactor for the lecithin cholesterol acyltransferase (LCAT). As part of the SPAP complex, activates spermatozoa motility.</text>
</comment>
<comment type="subunit">
<text evidence="4 9 10 11">Interacts with APOA1BP and CLU. Component of a sperm activating protein complex (SPAP), consisting of APOA1, an immunoglobulin heavy chain, an immunoglobulin light chain and albumin. Interacts with NDRG1.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-701692"/>
<interactant intactId="EBI-701692"/>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-701692"/>
<interactant intactId="EBI-784112">
<id>O95477</id>
<label>ABCA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-701692"/>
<interactant intactId="EBI-77613">
<id>P05067</id>
<label>APP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-701692"/>
<interactant intactId="EBI-2548702">
<id>Q96DZ9</id>
<label>CMTM5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-701692"/>
<interactant intactId="EBI-348571">
<id>P02671</id>
<label>FGA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-701692"/>
<interactant intactId="EBI-1220767">
<id>P00738</id>
<label>HP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="5">Major protein of plasma HDL, also found in chylomicrons. Synthesized in the liver and small intestine. The oxidized form at Met-110 and Met-136 is increased in individuals with increased risk for coronary artery disease, such as in carrier of the eNOSa/b genotype and exposure to cigarette smoking. It is also present in increased levels in aortic lesions relative to native ApoA-I and increased levels are seen with increasing severity of disease.</text>
</comment>
<comment type="PTM">
<text evidence="3">Glycosylated.</text>
</comment>
<comment type="PTM">
<text evidence="20">Palmitoylated.</text>
</comment>
<comment type="PTM">
<text>Phosphorylation sites are present in the extracellular medium.</text>
</comment>
<comment type="mass spectrometry" mass="28081" method="Electrospray" evidence="5">
<location>
<begin position="25"/>
<end position="267"/>
</location>
<text>Without methionine sulfoxide.</text>
</comment>
<comment type="mass spectrometry" mass="28098" method="Electrospray" evidence="5">
<location>
<begin position="25"/>
<end position="267"/>
</location>
<text>With 1 methionine sulfoxide, oxidation at Met-110.</text>
</comment>
<comment type="mass spectrometry" mass="28095" method="Electrospray" evidence="5">
<location>
<begin position="25"/>
<end position="267"/>
</location>
<text>With 1 methionine sulfoxide, oxidation at Met-136.</text>
</comment>
<comment type="mass spectrometry" mass="28114" method="Electrospray" evidence="5">
<location>
<begin position="25"/>
<end position="267"/>
</location>
<text>With 2 methionine sulfoxides, oxidation at Met-110 and Met-136.</text>
</comment>
<comment type="polymorphism">
<text evidence="30">Genetic variations in APOA1 can result in APOA1 deficiency and are associated with low levels of HDL cholesterol [MIM:107680].</text>
</comment>
<comment type="disease">
<disease id="DI-01743">
<name>High density lipoprotein deficiency 2</name>
<acronym>HDLD2</acronym>
<description>Inherited as autosomal dominant trait. It is characterized by moderately low HDL cholesterol, predilection toward premature coronary artery disease (CAD) and a reduction in cellular cholesterol efflux.</description>
<dbReference type="MIM" id="604091"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<disease id="DI-01742">
<name>High density lipoprotein deficiency 1</name>
<acronym>HDLD1</acronym>
<description>Recessive disorder characterized by absence of high density lipoprotein (HDL) cholesterol from plasma, accumulation of cholesteryl esters, premature coronary artery disease (CAD), hepatosplenomegaly, recurrent peripheral neuropathy and progressive muscle wasting and weakness.</description>
<dbReference type="MIM" id="205400"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text>APOA1 mutations may be involved in the pathogenesis of amyloid polyneuropathy-nephropathy Iowa type, also known as amyloidosis van Allen type or familial amyloid polyneuropathy type III (PubMed:3142462 and PubMed:2123470). The clinical picture is dominated by neuropathy in the early stages of the disease and nephropathy late in the course. Death is due in most cases to renal amyloidosis.</text>
</comment>
<comment type="disease" evidence="7 15 21 27">
<disease id="DI-00104">
<name>Amyloidosis 8</name>
<acronym>AMYL8</acronym>
<description>A hereditary generalized amyloidosis due to deposition of apolipoprotein A1, fibrinogen and lysozyme amyloids. Viscera are particularly affected. There is no involvement of the nervous system. Clinical features include renal amyloidosis resulting in nephrotic syndrome, arterial hypertension, hepatosplenomegaly, cholestasis, petechial skin rash.</description>
<dbReference type="MIM" id="105200"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="30">Belongs to the apolipoprotein A1/A4/E family.</text>
</comment>
<comment type="online information" name="SHMPD">
<link uri="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&amp;genename=APOA1"/>
<text>The Singapore human mutation and polymorphism database</text>
</comment>
<dbReference type="EMBL" id="J00098">
<property type="protein sequence ID" value="AAB59514.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X01038">
<property type="protein sequence ID" value="CAA25519.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X02162">
<property type="protein sequence ID" value="CAA26097.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X00566">
<property type="protein sequence ID" value="CAA25232.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M11791">
<property type="protein sequence ID" value="AAA35545.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X07496">
<property type="protein sequence ID" value="CAA30377.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M27875">
<property type="protein sequence ID" value="AAA62829.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M29068">
<property type="protein sequence ID" value="AAA51747.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY422952">
<property type="protein sequence ID" value="AAQ91811.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY555191">
<property type="protein sequence ID" value="AAS68227.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="A14829">
<property type="protein sequence ID" value="CAA01198.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK292231">
<property type="protein sequence ID" value="BAF84920.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF444948">
<property type="protein sequence ID" value="ACA05932.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EF444948">
<property type="protein sequence ID" value="ACA05933.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EF444948">
<property type="protein sequence ID" value="ACA05934.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EF444948">
<property type="protein sequence ID" value="ACA05935.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EF444948">
<property type="protein sequence ID" value="ACA05936.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471065">
<property type="protein sequence ID" value="EAW67274.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC005380">
<property type="protein sequence ID" value="AAH05380.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC110286">
<property type="protein sequence ID" value="AAI10287.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS8378.1"/>
<dbReference type="PIR" id="A90947">
<property type="entry name" value="LPHUA1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000030.1">
<property type="nucleotide sequence ID" value="NM_000039.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001304946.1">
<property type="nucleotide sequence ID" value="NM_001318017.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001304947.1">
<property type="nucleotide sequence ID" value="NM_001318018.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001304950.1">
<property type="nucleotide sequence ID" value="NM_001318021.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.93194"/>
<dbReference type="PDB" id="1AV1">
<property type="method" value="X-ray"/>
<property type="resolution" value="4.00"/>
<property type="chains" value="A/B/C/D=68-267"/>
</dbReference>
<dbReference type="PDB" id="1GW3">
<property type="method" value="NMR"/>
<property type="chains" value="A=166-211"/>
</dbReference>
<dbReference type="PDB" id="1GW4">
<property type="method" value="NMR"/>
<property type="chains" value="A=166-211"/>
</dbReference>
<dbReference type="PDB" id="1ODP">
<property type="method" value="NMR"/>
<property type="chains" value="A=190-209"/>
</dbReference>
<dbReference type="PDB" id="1ODQ">
<property type="method" value="NMR"/>
<property type="chains" value="A=190-209"/>
</dbReference>
<dbReference type="PDB" id="1ODR">
<property type="method" value="NMR"/>
<property type="chains" value="A=190-209"/>
</dbReference>
<dbReference type="PDB" id="2A01">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B/C=25-267"/>
</dbReference>
<dbReference type="PDB" id="2MSC">
<property type="method" value="NMR"/>
<property type="chains" value="A/C=68-265"/>
</dbReference>
<dbReference type="PDB" id="2MSD">
<property type="method" value="NMR"/>
<property type="chains" value="A/C=68-265"/>
</dbReference>
<dbReference type="PDB" id="2MSE">
<property type="method" value="NMR"/>
<property type="chains" value="A/C=68-265"/>
</dbReference>
<dbReference type="PDB" id="3K2S">
<property type="method" value="X-ray"/>
<property type="chains" value="A/B=25-267"/>
</dbReference>
<dbReference type="PDB" id="3R2P">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=25-208"/>
</dbReference>
<dbReference type="PDB" id="4V6M">
<property type="method" value="EM"/>
<property type="resolution" value="7.10"/>
<property type="chains" value="A0/A1=68-267"/>
</dbReference>
<dbReference type="PDBsum" id="1AV1"/>
<dbReference type="PDBsum" id="1GW3"/>
<dbReference type="PDBsum" id="1GW4"/>
<dbReference type="PDBsum" id="1ODP"/>
<dbReference type="PDBsum" id="1ODQ"/>
<dbReference type="PDBsum" id="1ODR"/>
<dbReference type="PDBsum" id="2A01"/>
<dbReference type="PDBsum" id="2MSC"/>
<dbReference type="PDBsum" id="2MSD"/>
<dbReference type="PDBsum" id="2MSE"/>
<dbReference type="PDBsum" id="3K2S"/>
<dbReference type="PDBsum" id="3R2P"/>
<dbReference type="PDBsum" id="4V6M"/>
<dbReference type="DisProt" id="DP00386"/>
<dbReference type="ProteinModelPortal" id="P02647"/>
<dbReference type="SMR" id="P02647">
<property type="residue range" value="26-267"/>
</dbReference>
<dbReference type="BioGrid" id="106832">
<property type="interactions" value="87"/>
</dbReference>
<dbReference type="DIP" id="DIP-29619N"/>
<dbReference type="IntAct" id="P02647">
<property type="interactions" value="70"/>
</dbReference>
<dbReference type="MINT" id="MINT-5000866"/>
<dbReference type="STRING" id="9606.ENSP00000236850"/>
<dbReference type="ChEMBL" id="CHEMBL5984"/>
<dbReference type="iPTMnet" id="P02647"/>
<dbReference type="PhosphoSite" id="P02647"/>
<dbReference type="BioMuta" id="APOA1"/>
<dbReference type="DMDM" id="113992"/>
<dbReference type="DOSAC-COBS-2DPAGE" id="P02647"/>
<dbReference type="OGP" id="P02647"/>
<dbReference type="REPRODUCTION-2DPAGE" id="IPI00021841"/>
<dbReference type="REPRODUCTION-2DPAGE" id="P02647"/>
<dbReference type="SWISS-2DPAGE" id="P02647"/>
<dbReference type="UCD-2DPAGE" id="P02647"/>
<dbReference type="EPD" id="P02647"/>
<dbReference type="MaxQB" id="P02647"/>
<dbReference type="PaxDb" id="P02647"/>
<dbReference type="PeptideAtlas" id="P02647"/>
<dbReference type="PRIDE" id="P02647"/>
<dbReference type="DNASU" id="335"/>
<dbReference type="Ensembl" id="ENST00000236850">
<property type="protein sequence ID" value="ENSP00000236850"/>
<property type="gene ID" value="ENSG00000118137"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000359492">
<property type="protein sequence ID" value="ENSP00000352471"/>
<property type="gene ID" value="ENSG00000118137"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000375320">
<property type="protein sequence ID" value="ENSP00000364469"/>
<property type="gene ID" value="ENSG00000118137"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000375323">
<property type="protein sequence ID" value="ENSP00000364472"/>
<property type="gene ID" value="ENSG00000118137"/>
</dbReference>
<dbReference type="GeneID" id="335"/>
<dbReference type="KEGG" id="hsa:335"/>
<dbReference type="UCSC" id="uc001ppv.2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="335"/>
<dbReference type="GeneCards" id="APOA1"/>
<dbReference type="HGNC" id="HGNC:600">
<property type="gene designation" value="APOA1"/>
</dbReference>
<dbReference type="HPA" id="CAB016778"/>
<dbReference type="HPA" id="HPA046715"/>
<dbReference type="MalaCards" id="APOA1"/>
<dbReference type="MIM" id="105200">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="107680">
<property type="type" value="gene+phenotype"/>
</dbReference>
<dbReference type="MIM" id="205400">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="604091">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P02647"/>
<dbReference type="Orphanet" id="425">
<property type="disease" value="Apolipoprotein A-I deficiency"/>
</dbReference>
<dbReference type="Orphanet" id="93560">
<property type="disease" value="Familial renal amyloidosis due to Apolipoprotein AI variant"/>
</dbReference>
<dbReference type="Orphanet" id="314701">
<property type="disease" value="Primary systemic amyloidosis"/>
</dbReference>
<dbReference type="PharmGKB" id="PA49"/>
<dbReference type="eggNOG" id="ENOG410IWKR">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410YGQ6">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00530000063081"/>
<dbReference type="HOGENOM" id="HOG000033998"/>
<dbReference type="HOVERGEN" id="HBG105708"/>
<dbReference type="InParanoid" id="P02647"/>
<dbReference type="KO" id="K08757"/>
<dbReference type="OMA" id="KDFATVY"/>
<dbReference type="OrthoDB" id="EOG7TBC3N"/>
<dbReference type="PhylomeDB" id="P02647"/>
<dbReference type="TreeFam" id="TF334458"/>
<dbReference type="Reactome" id="R-HSA-114608">
<property type="pathway name" value="Platelet degranulation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1369062">
<property type="pathway name" value="ABC transporters in lipid homeostasis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-174800">
<property type="pathway name" value="Chylomicron-mediated lipid transport"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-194223">
<property type="pathway name" value="HDL-mediated lipid transport"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1989781">
<property type="pathway name" value="PPARA activates gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2168880">
<property type="pathway name" value="Scavenging of heme from plasma"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3000471">
<property type="pathway name" value="Scavenging by Class B Receptors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3000480">
<property type="pathway name" value="Scavenging by Class A Receptors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-975634">
<property type="pathway name" value="Retinoid metabolism and transport"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-977225">
<property type="pathway name" value="Amyloid fiber formation"/>
</dbReference>
<dbReference type="ChiTaRS" id="APOA1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P02647"/>
<dbReference type="GeneWiki" id="Apolipoprotein_A1"/>
<dbReference type="GenomeRNAi" id="335"/>
<dbReference type="NextBio" id="1387"/>
<dbReference type="PMAP-CutDB" id="P02647"/>
<dbReference type="PRO" id="PR:P02647"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 11"/>
</dbReference>
<dbReference type="Bgee" id="P02647"/>
<dbReference type="CleanEx" id="HS_APOA1"/>
<dbReference type="ExpressionAtlas" id="P02647">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P02647">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0072562">
<property type="term" value="C:blood microparticle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042627">
<property type="term" value="C:chylomicron"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0031410">
<property type="term" value="C:cytoplasmic vesicle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034365">
<property type="term" value="C:discoidal high-density lipoprotein particle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005769">
<property type="term" value="C:early endosome"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030139">
<property type="term" value="C:endocytic vesicle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071682">
<property type="term" value="C:endocytic vesicle lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005788">
<property type="term" value="C:endoplasmic reticulum lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903561">
<property type="term" value="C:extracellular vesicle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034364">
<property type="term" value="C:high-density lipoprotein particle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034774">
<property type="term" value="C:secretory granule lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034366">
<property type="term" value="C:spherical high-density lipoprotein particle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034361">
<property type="term" value="C:very-low-density lipoprotein particle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034191">
<property type="term" value="F:apolipoprotein A-I receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034190">
<property type="term" value="F:apolipoprotein receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001540">
<property type="term" value="F:beta-amyloid binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045499">
<property type="term" value="F:chemorepellent activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015485">
<property type="term" value="F:cholesterol binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0017127">
<property type="term" value="F:cholesterol transporter activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008035">
<property type="term" value="F:high-density lipoprotein particle binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070653">
<property type="term" value="F:high-density lipoprotein particle receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0055102">
<property type="term" value="F:lipase inhibitor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031210">
<property type="term" value="F:phosphatidylcholine binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0060228">
<property type="term" value="F:phosphatidylcholine-sterol O-acyltransferase activator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005543">
<property type="term" value="F:phospholipid binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005548">
<property type="term" value="F:phospholipid transporter activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030325">
<property type="term" value="P:adrenal gland development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007596">
<property type="term" value="P:blood coagulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043534">
<property type="term" value="P:blood vessel endothelial cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0044255">
<property type="term" value="P:cellular lipid metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0044267">
<property type="term" value="P:cellular protein metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006695">
<property type="term" value="P:cholesterol biosynthetic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0033344">
<property type="term" value="P:cholesterol efflux"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042632">
<property type="term" value="P:cholesterol homeostasis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070508">
<property type="term" value="P:cholesterol import"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008203">
<property type="term" value="P:cholesterol metabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030301">
<property type="term" value="P:cholesterol transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0001935">
<property type="term" value="P:endothelial cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006775">
<property type="term" value="P:fat-soluble vitamin metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007186">
<property type="term" value="P:G-protein coupled receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008211">
<property type="term" value="P:glucocorticoid metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034380">
<property type="term" value="P:high-density lipoprotein particle assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034384">
<property type="term" value="P:high-density lipoprotein particle clearance"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034375">
<property type="term" value="P:high-density lipoprotein particle remodeling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007229">
<property type="term" value="P:integrin-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019915">
<property type="term" value="P:lipid storage"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042158">
<property type="term" value="P:lipoprotein biosynthetic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042157">
<property type="term" value="P:lipoprotein metabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0050919">
<property type="term" value="P:negative chemotaxis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060354">
<property type="term" value="P:negative regulation of cell adhesion molecule production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002740">
<property type="term" value="P:negative regulation of cytokine secretion involved in immune response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034115">
<property type="term" value="P:negative regulation of heterotypic cell-cell adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050728">
<property type="term" value="P:negative regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050713">
<property type="term" value="P:negative regulation of interleukin-1 beta secretion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060192">
<property type="term" value="P:negative regulation of lipase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060761">
<property type="term" value="P:negative regulation of response to cytokine stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010804">
<property type="term" value="P:negative regulation of tumor necrosis factor-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010903">
<property type="term" value="P:negative regulation of very-low-density lipoprotein particle remodeling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031102">
<property type="term" value="P:neuron projection regeneration"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0031100">
<property type="term" value="P:organ regeneration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0018206">
<property type="term" value="P:peptidyl-methionine modification"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014012">
<property type="term" value="P:peripheral nervous system axon regeneration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006656">
<property type="term" value="P:phosphatidylcholine biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033700">
<property type="term" value="P:phospholipid efflux"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0055091">
<property type="term" value="P:phospholipid homeostasis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007603">
<property type="term" value="P:phototransduction, visible light"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030168">
<property type="term" value="P:platelet activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002576">
<property type="term" value="P:platelet degranulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0010873">
<property type="term" value="P:positive regulation of cholesterol esterification"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045723">
<property type="term" value="P:positive regulation of fatty acid biosynthetic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0051345">
<property type="term" value="P:positive regulation of hydrolase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051006">
<property type="term" value="P:positive regulation of lipoprotein lipase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0035025">
<property type="term" value="P:positive regulation of Rho protein signal transduction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051496">
<property type="term" value="P:positive regulation of stress fiber assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900026">
<property type="term" value="P:positive regulation of substrate adhesion-dependent cell spreading"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010898">
<property type="term" value="P:positive regulation of triglyceride catabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0018158">
<property type="term" value="P:protein oxidation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050821">
<property type="term" value="P:protein stabilization"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006898">
<property type="term" value="P:receptor-mediated endocytosis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032489">
<property type="term" value="P:regulation of Cdc42 protein signal transduction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030300">
<property type="term" value="P:regulation of intestinal cholesterol absorption"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0001932">
<property type="term" value="P:regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043627">
<property type="term" value="P:response to estrogen"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007584">
<property type="term" value="P:response to nutrient"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001523">
<property type="term" value="P:retinoid metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043691">
<property type="term" value="P:reverse cholesterol transport"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0044281">
<property type="term" value="P:small molecule metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0055085">
<property type="term" value="P:transmembrane transport"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0019433">
<property type="term" value="P:triglyceride catabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0070328">
<property type="term" value="P:triglyceride homeostasis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034372">
<property type="term" value="P:very-low-density lipoprotein particle remodeling"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006766">
<property type="term" value="P:vitamin metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051180">
<property type="term" value="P:vitamin transport"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="InterPro" id="IPR000074">
<property type="entry name" value="ApoA_E"/>
</dbReference>
<dbReference type="Pfam" id="PF01442">
<property type="entry name" value="Apolipoprotein"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0034">Amyloid</keyword>
<keyword id="KW-1008">Amyloidosis</keyword>
<keyword id="KW-0065">Atherosclerosis</keyword>
<keyword id="KW-0153">Cholesterol metabolism</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0971">Glycation</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0345">HDL</keyword>
<keyword id="KW-0443">Lipid metabolism</keyword>
<keyword id="KW-0445">Lipid transport</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0622">Neuropathy</keyword>
<keyword id="KW-0558">Oxidation</keyword>
<keyword id="KW-0564">Palmitate</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0753">Steroid metabolism</keyword>
<keyword id="KW-1207">Sterol metabolism</keyword>
<keyword id="KW-0813">Transport</keyword>
<feature type="signal peptide" evidence="22 24">
<location>
<begin position="1"/>
<end position="18"/>
</location>
</feature>
<feature type="chain" description="Proapolipoprotein A-I" id="PRO_0000425323">
<location>
<begin position="19"/>
<end position="267"/>
</location>
</feature>
<feature type="chain" description="Apolipoprotein A-I" id="PRO_0000001939">
<location>
<begin position="25"/>
<end position="267"/>
</location>
</feature>
<feature type="chain" description="Truncated apolipoprotein A-I" id="PRO_0000001940">
<location>
<begin position="25"/>
<end position="266"/>
</location>
</feature>
<feature type="repeat" description="1">
<location>
<begin position="68"/>
<end position="89"/>
</location>
</feature>
<feature type="repeat" description="2">
<location>
<begin position="90"/>
<end position="111"/>
</location>
</feature>
<feature type="repeat" description="3; half-length">
<location>
<begin position="112"/>
<end position="122"/>
</location>
</feature>
<feature type="repeat" description="4">
<location>
<begin position="123"/>
<end position="144"/>
</location>
</feature>
<feature type="repeat" description="5">
<location>
<begin position="145"/>
<end position="166"/>
</location>
</feature>
<feature type="repeat" description="6">
<location>
<begin position="167"/>
<end position="188"/>
</location>
</feature>
<feature type="repeat" description="7">
<location>
<begin position="189"/>
<end position="210"/>
</location>
</feature>
<feature type="repeat" description="8">
<location>
<begin position="211"/>
<end position="232"/>
</location>
</feature>
<feature type="repeat" description="9; half-length">
<location>
<begin position="233"/>
<end position="243"/>
</location>
</feature>
<feature type="repeat" description="10">
<location>
<begin position="244"/>
<end position="267"/>
</location>
</feature>
<feature type="region of interest" description="10 X approximate tandem repeats">
<location>
<begin position="68"/>
<end position="267"/>
</location>
</feature>
<feature type="modified residue" description="Methionine sulfoxide" evidence="5">
<location>
<position position="110"/>
</location>
</feature>
<feature type="modified residue" description="Methionine sulfoxide" evidence="5">
<location>
<position position="136"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (Glc) (glycation)">
<location>
<position position="263"/>
</location>
</feature>
<feature type="sequence variant" description="In Munster-3C; dbSNP:rs121912720." id="VAR_000605">
<original>P</original>
<variation>H</variation>
<location>
<position position="27"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs121912720." id="VAR_000606" evidence="18">
<original>P</original>
<variation>R</variation>
<location>
<position position="27"/>
</location>
</feature>
<feature type="sequence variant" description="In Munster-3B." id="VAR_000607" evidence="18">
<original>P</original>
<variation>R</variation>
<location>
<position position="28"/>
</location>
</feature>
<feature type="sequence variant" description="In Baltimore; dbSNP:rs28929476." id="VAR_000608" evidence="13">
<original>R</original>
<variation>L</variation>
<location>
<position position="34"/>
</location>
</feature>
<feature type="sequence variant" description="In AMYL8; also found in a family with amyloid polyneuropathy-nephropathy Iowa; dbSNP:rs28931574." id="VAR_000609" evidence="15 21 27">
<original>G</original>
<variation>R</variation>
<location>
<position position="50"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs12718465." id="VAR_025445" evidence="8">
<original>A</original>
<variation>T</variation>
<location>
<position position="61"/>
</location>
</feature>
<feature type="sequence variant" description="In AMYL8." id="VAR_000610" evidence="7">
<original>L</original>
<variation>R</variation>
<location>
<position position="84"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; confirmed at protein level." id="VAR_017017" evidence="6 16">
<original>T</original>
<variation>I</variation>
<location>
<position position="92"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_000611" evidence="14">
<original>D</original>
<variation>E</variation>
<location>
<position position="113"/>
</location>
</feature>
<feature type="sequence variant" description="In Hita." id="VAR_000612">
<original>A</original>
<variation>D</variation>
<location>
<position position="119"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5077." id="VAR_016189">
<original>D</original>
<variation>H</variation>
<location>
<position position="126"/>
</location>
</feature>
<feature type="sequence variant" description="In Munster-3A." id="VAR_000613">
<original>D</original>
<variation>N</variation>
<location>
<position position="127"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4882." id="VAR_000615" evidence="14">
<original>K</original>
<variation>M</variation>
<location>
<position position="131"/>
</location>
</feature>
<feature type="sequence variant" description="In Marburg/Munster-2." id="VAR_000614">
<location>
<position position="131"/>
</location>
</feature>
<feature type="sequence variant" description="In Tsushima." id="VAR_000616">
<original>W</original>
<variation>R</variation>
<location>
<position position="132"/>
</location>
</feature>
<feature type="sequence variant" description="In Fukuoka." id="VAR_000617" evidence="12">
<original>E</original>
<variation>K</variation>
<location>
<position position="134"/>
</location>
</feature>
<feature type="sequence variant" description="In Norway." id="VAR_000618" evidence="25">
<original>E</original>
<variation>K</variation>
<location>
<position position="160"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_000619" evidence="14">
<original>E</original>
<variation>G</variation>
<location>
<position position="163"/>
</location>
</feature>
<feature type="sequence variant" description="In Giessen." id="VAR_000620" evidence="26">
<original>P</original>
<variation>R</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="sequence variant" description="In Zaragoza." id="VAR_000621" evidence="29">
<original>L</original>
<variation>R</variation>
<location>
<position position="168"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_000622" evidence="14">
<original>E</original>
<variation>V</variation>
<location>
<position position="171"/>
</location>
</feature>
<feature type="sequence variant" description="In Boston; no evidence of association with premature coronary heart disease; associated with decreased levels of HDL cholesterol; associated with decreased serum cellular cholesterol efflux; associated with decreased lecithin-cholesterol acyltransferase (LCAT) activity." id="VAR_074073" evidence="19">
<original>R</original>
<variation>S</variation>
<location>
<position position="173"/>
</location>
</feature>
<feature type="sequence variant" description="In Oita; 60% of normal apoA-I and normal HDL cholesterol levels. Rapidly cleared from plasma." id="VAR_021362" evidence="28">
<original>V</original>
<variation>E</variation>
<location>
<position position="180"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5078." id="VAR_014609">
<original>R</original>
<variation>P</variation>
<location>
<position position="184"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_000623" evidence="18">
<original>P</original>
<variation>R</variation>
<location>
<position position="189"/>
</location>
</feature>
<feature type="sequence variant" description="In Milano; no evidence of association with premature vascular disease; associated with decreased HDL levels and moderate increase in triglycerides; allows the formation of disulfide-linked homodimers via the introduced cysteine; assembles properly in HDL; alters protein structure; has no tendency to form fibrils and aggregates; dbSNP:rs28931573." id="VAR_000624" evidence="17 23">
<original>R</original>
<variation>C</variation>
<location>
<position position="197"/>
</location>
</feature>
<feature type="sequence variant" description="In Munster-4." id="VAR_000625" evidence="14">
<original>E</original>
<variation>K</variation>
<location>
<position position="222"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 25; AA sequence." ref="25" evidence="30">
<original>W</original>
<variation>P</variation>
<location>
<position position="32"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="33"/>
<end position="42"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="45"/>
<end position="59"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="61"/>
<end position="65"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="69"/>
<end position="73"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="80"/>
<end position="88"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="93"/>
<end position="158"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="159"/>
<end position="164"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="166"/>
<end position="203"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="212"/>
<end position="214"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="215"/>
<end position="217"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="220"/>
<end position="237"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="238"/>
<end position="240"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="243"/>
<end position="266"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2A01"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3R2P"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250"/>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11991719"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12576517"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12966036"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1502149"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15108119"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15922294"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1742316"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1909888"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2107878"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2108924"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2111322"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2123470"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22028381"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24755625"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2512329"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26073399"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3005308"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3142462"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="6328445"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="6401735"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="6409108"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="6432779"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="6489332"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8208902"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9514407"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source ref="56"/>
</evidence>
<evidence key="30" type="ECO:0000305"/>
<sequence length="267" mass="30778" checksum="1A28B8366E620310" modified="1986-07-21" version="1" precursor="true">
MKAAVLTLAVLFLTGSQARHFWQQDEPPQSPWDRVKDLATVYVDVLKDSGRDYVSQFEGS
ALGKQLNLKLLDNWDSVTSTFSKLREQLGPVTQEFWDNLEKETEGLRQEMSKDLEEVKAK
VQPYLDDFQKKWQEEMELYRQKVEPLRAELQEGARQKLHELQEKLSPLGEEMRDRARAHV
DALRTHLAPYSDELRQRLAARLEALKENGGARLAEYHAKATEHLSTLSEKAKPALEDLRQ
GLLPVLESFKVSFLSALEEYTKKLNTQ
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>